Alvotech reports positive results in study for Xolair biosimilar
Source: SeekingAlpha
2025-06-25 09:15:02 ET
More on Alvotech, Roche Holding, etc.
- Novartis: A SWAN Worth Owning
- Roche Holding AG (RHHBY) Virtual Hematology Investor Conference Transcript
- Virtual Hematology Investor Conference
- Roche's Genentech reports positive results from lymphoma trial
- Lower interest rates, drug pricing reform clarity are catalysts for biotech M&A market
Read the full article on Seeking Alpha
For further details see:
Alvotech reports positive results in study for Xolair biosimilar
Alvotech
NASDAQ: ALVO
ALVO Trading
-6.23% G/L:
$3.01 Last:
679,105 Volume:
$3.23 Open:
ALVO Latest News
May 11, 2026 04:30:00 am
Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility
ALVO Stock Data
$1,569,389,520
107,654,085
N/A
30
N/A
Pharmaceuticals
Healthcare
LU
Luxembourg
